National Lung Screening Trial Results
|
|
- Bryan Baldwin
- 5 years ago
- Views:
Transcription
1 National Lung Screening Trial Results Ella A. Kazerooni, M.D. Professor & Director Cardiothoracic Radiology Associate Chair for Clinical Affairs University of Michigan
2 NLST STOPPED! Lung cancer trial results show mortality benefit with low-dose CT 11/4/10 NCI Press Conference & Press Release The trials independent Data Safety Monitoring Board notified the NCI Director that the accumulated data provided statistically convincing answer to the study s primary question. This is the first time that we have seen clear evidence of a significant reduction in lung cancer mortality with a screening test in a randomized controlled trial. Christine Berg if low-dose helical CT screening is implemented responsibly and individuals with abnormalities are judiciously followed, we have the potential to save thousands of lives. Denise Aberle
3 NLST: Interim Primary Endpoint Analysis Reported by DSMB Oct. 20, 2010 Arm Person years (py) Lung cancer deaths Lung cancer mortality per 100,000 py Reduction in lung cancer mortality (%) Value of test statistic Efficacy boundary CT 144, CXR 143, Deficit of lung cancer deaths in CT arm exceeds that expected by chance, even allowing for multiple looks at the data
4 NLST: Interim Secondary Endpoint Analysis Reported by DSMB Oct. 20, 2010 Arm Person years (py) Deaths All-cause mortality per 100,000 py Reduction in all-cause mortality (%) Value of test statistic Value for significance CT 167, CXR 166, Deficit of deaths in CT arm exceeds that expected by chance.
5
6 NLST: Subjects Age & Gender
7 NLST: Subjects Race/Ethnicity
8 NLST: Subjects Smoking History
9 NLST: Family History of Lung Cancer CT CXR Total Any first degree relative 21.8 % 21.7 % 21.7 % Two or more first degree relatives 3.3 % 3.2 % 3.3 %
10 NLST Demographics vs. US Population U.S Census Department Tobacco Use Supplement of Continuing Population Survey for Information on 240,000 respondents Reviewed subset of respondents aged 55-74, with 30+ pack year smoking, either current smoker or former smoker who quit within the past 15 years Identified smoking status, age, sex, race, ethnicity, marital status, and education
11 NLST Demographics vs. US Population NLST US Census Male (%) Age (%) (%) (%) (%) Race/ethnicity Black (%) Hispanic (%)
12 NLST Demographics vs. US Population NLST US Census Married Education < HS College Current smoker Median pack years
13 NLST Demographics vs. US Population Compared with similar US population, NLST subjects have: similar gender distribution and smoking exposure are younger better educated less likely to be current smokers
14 Screening Exam Compliance & Crossover Study Year CT CXR Total Expected Screened Expected Screened Expected Screened T0 26, % 26, % 53, % T1 26, % 26, % 52, % T2 25, % 26, % 52, % Compliance: 95% CT arm & 93% CXR arm Crossover: 4.3% in LSS CXR arm underwent CT
15 NLST: Screen Positivity* Rate CT CXR Screening Round # screened # positive % positive # screened # positive % positive 1 26,309 7, ,035 2, ,715 6, ,089 1, ,102 4, ** 23,346 1, ** All 3 75,126 18, ,499 5, *A positive screen is one that may be suspicious for lung cancer. **A suspicious abnormality that has been stable for 3 rounds may be called negative according to protocol.
16 NLST: True and False Positive Screens CT CXR Round 1 N (%) Round 2 N (%) Round 3 N (%) Round 1 N (%) Round 2 N (%) Round 3 N (%) Total positives 7,193 (100) 6,902 (100) 4,054 (100) 2,387 (100) 1,482 (100) 1,175 (100) With lung cancer 270 (4) 168 (2) 211 (5) 136 (6) 65 (4) 78 (7) Without lung cancer 6,923 (96) 6,734 (98) 3,843 (95) 2,251 (94) 1,417 (96) 1,097 (93)
17 indeterminate lung nodule
18 NLST (+) CT screen & diagnostic tests 1.4% experienced a complication 28% among those determined to have lung cancer 0.35% determined to not have lung cancer 16 deaths due to medical interventions hastened the death of 16 people of the 16, 10 had lung cancer and 6 did not risk of death in non-cancer patients 0.024%
19 NLST: Clinically Significant Non Lung Cancer CT CXR Screening Round # screened # positive % positive # screened # positive % positive 1 26, , , , , , All 3 75, ,
20 NLST: Cumulative # of Lung Cancers
21 NLST: Cumulative # of Lung Cancer Deaths
22 Kaplan-Meier Curves for Lung Cancer Mortality
23 Kaplan-Meier Curves for All-Cause Mortality
24 Kaplan-Meier Curves for Lung Cancer Case Survival (Lung Cancer Cause of Death) Table d
25 National Lung Screening Trial Results Ella A. Kazerooni, M.D. Professor & Director Cardiothoracic Radiology Associate Chair for Clinical Affairs University of Michigan
A Comprehensive Cancer Center Designated by the National Cancer Institute
N C I C C C A Comprehensive Cancer Center Designated by the National Cancer Institute Screening and Early Detection of Lung Cancer: Ready for Practice? David S. Ettinger, MD, FACP, FCCP Alex Grass Professor
More informationScreening Programs background and clinical implementation. Denise R. Aberle, MD Professor of Radiology and Engineering
Screening Programs background and clinical implementation Denise R. Aberle, MD Professor of Radiology and Engineering disclosures I have no disclosures. I have no conflicts of interest relevant to this
More information6/6/2011. Recruitment methods employed in the. Pamela Marcus, PhD. National Cancer Institute NLST
Recruitment methods employed in the National Lung Screening Trial (NLST) Pamela Marcus, PhD Division of Cancer Prevention National Cancer Institute NLST 1 NLST: The basics Sponsored by the US National
More informationCurrent Approach to Screening for Lung Cancer. James R Jett M.D.
Current Approach to Screening for Lung Cancer James R Jett M.D. Potential Conflicts of Interest I am Chief Medical Officer for Oncimmune Ltd (Biomarkers of Cancer) Co-Editor of Lung Cancer Section of UP-TO-DATE
More informationLessons learned for the conduct of a successful screening trial
Lessons learned for the conduct of a successful screening trial Christine D. Berg, M.D. Adjunct Professor Department of Radiation Oncology Johns Hopkins Medicine IOM State of the Science in Ovarian Cancer
More informationPulmonologist s Perspective
Low-dose CT for lung cancer screening Pulmonologist s Perspective Literature Review Kang-Yun Lee, MD PhD Department of Thoracic Medicine Taipei Medical University- Shuang Ho Hospital Taiwan Local vs. Advanced
More informationCT screening for lung cancer. Should it be done in the Indian context?
CT screening for lung cancer Should it be done in the Indian context? Wilson and Jungner screening criteria 1. The condition sought should be an important health problem. 2. There should be an accepted
More informationCT Screening for Lung Cancer for High Risk Patients
CT Screening for Lung Cancer for High Risk Patients The recently published National Lung Cancer Screening Trial (NLST) showed that low-dose CT screening for lung cancer reduces mortality in high-risk patients
More informationOutcomes in the NLST. Health system infrastructure needs to implement screening
Outcomes in the NLST Health system infrastructure needs to implement screening Denise R. Aberle, MD Professor of Radiology and Bioengineering David Geffen School of Medicine at UCLA 1 Disclosures I have
More informationLung Cancer Screening
Lung Cancer Screening Ravi Salgia, M.D., Ph.D. Professor and Chair Medical Oncology and Therapeutics Research City of Hope Nothing to disclose Disclosure Lung Cancer 2016 >200,000 cases projected >160,000
More informationNew Advances in Lung Cancer
New Advances in Lung Cancer Douglas E. Wood, MD, FACS, FRCSEd (ad hom) Professor and Chief Division of Cardiothoracic Surgery Vice-Chair, Department of Surgery Endowed Chair in Lung Cancer Research University
More informationUltralow Dose Chest CT with MBIR
Ultralow Dose Chest CT with MBIR Ella A. Kazerooni, M.D. Professor & Director Cardiothoracic Radiology Associate Chair for Clinical Affairs University of Michigan Disclosures Consultant: GE Healthcare
More informationLUNG CANCER SCREENING: LUNG CANCER SCREENING: THE TIME HAS COME LUNG CANCER: A NATIONAL EPIDEMIC
: THE TIME HAS COME Physician Leader, Lung Cancer Multi-Disciplinary Program Fletcher Allen Health Care Annual Meeting Montpelier, VT - April 25, 2014 Gerald S. Davis, MD Professor of Medicine University
More informationLung Cancer Screening: Now What?
Lung Cancer Screening: Now What? Gerold Bepler, M.D., Ph.D. Director, President & CEO Michigan Cancer Consortium, 2013 Annual Meeting, Lansing, MI, 11/20/13 Lung Cancer #1 Cause of Cancer Death for & *
More informationEquity Issues with Lung Cancer Screening Prevent Cancer - Quantitative Imaging Workshop November 5-6, 2018 Alexandria, VA
Equity Issues with Lung Cancer Screening Prevent Cancer - Quantitative Imaging Workshop November 5-6, 2018 Alexandria, VA Mary Pasquinelli, MS, APRN, FNP-BC Pulmonary and Thoracic Medical Oncology Director,
More informationAnn Intern Med. 2012;156(5):
Lung Cancer Screening Update Doug Arenberg, M.D. University of Michigan Outline Screening; Some simple but necessary truths Do people benefit from screening? What are the harms (and are they outweighed
More informationRobert J. McKenna M.D. Chief, Thoracic Surgery Cedars Sinai Medical Center
You Smoke, You Get Lung Cancer, You Die: Can Screening Change this Paradigm? Robert J. McKenna M.D. Chief, Thoracic Surgery Cedars Sinai Medical Center AATS Saturday 4/28/2012 Cancer Screening Cancer
More informationLung Cancer Screening: To screen or not to screen?
Lung Cancer Screening: To screen or not to screen? Dan J. Raz, M.D. Co Director, Lung Cancer Screening Program Co Director, LungCancer and Thoracic OncologyProgram Assistant Professor, Thoracic Surgery
More informationA Summary from the 2013World Conference on Lung Cancer Sydney, Australia
A Summary from the 2013World Conference on Lung Cancer Sydney, Australia In 2011, the U.S. National Lung Screening Trial (NLST) has demonstrated that low-dose computed tomography (LDCT) screening of high
More informationLung Cancer Screening
Lung Cancer Screening Steven Leh, MD, FCCP Diplomat of the American Association for Bronchology and Interventional Pulmonology Aurora Medical Group Pulmonary and Sleep Medicine February 10, 2018 Disclosures
More informationThe National Lung Screening Trial (NLST)
The National Lung Screening Trial (NLST) Pamela Marcus US National Cancer Institute May 21, 2012 Today s talk NLST: an overview Typical challenges in cancer screening RCTs Starting ti a trial in the presence
More informationVHA Demonstration Project for Lung Cancer Screening Using Low-Dose Chest CT Screening
VHA Demonstration Project for Lung Cancer Screening Using Low-Dose Chest CT Screening ATS San Francisco 2016 James K. Brown MD 1, Kathryn L. Rice, MD 2 (1) San Francisco VA (2) Minneapolis VAMC Disclosures
More informationLung Cancer Screening: Benefits and limitations to its Implementation
Lung Cancer Screening: Benefits and limitations to its Implementation Rolando Sanchez, MD Clinical Assistant Professor Pulmonary-Critical Care Medicine University of Iowa Lung cancer - Epidemiology Cancer
More informationSCREENING FOR EARLY LUNG CANCER. Pang Yong Kek
SCREENING FOR EARLY LUNG CANCER Pang Yong Kek Lecture Outline Why performing screening? How to improve early detection? Benefits and Risks of screening Challenges in screening Conclusion Why Performing
More informationThe complex, intertwined role of patients in research and care
Session 3: The complex, intertwined role of patients in research and care Joseph Chin, MD, MS, Acting Deputy Director, Coverage and Analysis Group, Centers for Medicare & Medicaid Services The complex,
More informationDisclosures. Overview. Selection the most accurate statement: Updates in Lung Cancer Screening 5/26/17. No Financial Disclosures
Updates in Lung Cancer Screening Disclosures No Financial Disclosures Neil Trivedi, MD Associate Professor of Clinical Medicine SF VAMC Pulmonary and Critical Care Director, Bronchoscopy & Interventional
More informationWhat to know and what to make of it
Lung Cancer Screening: What to know and what to make of it J. Matthew Reinersman, MD Assistant Professor of Surgery Division of Thoracic and Cardiovascular Surgery Department of Surgery University of Oklahoma
More informationLung Cancer and CT Screening
Lung Cancer and CT Screening Samer Kanaan, MD February 17 th, 2012 Goals Understand the Societal impact of Lung Cancer Identify Risk Factors for Lung Cancer List Diagnostic Tests Available for Lung Cancer
More informationLung Cancer Screening
Scan for mobile link. Lung Cancer Screening What is lung cancer screening? Screening examinations are tests performed to find disease before symptoms begin. The goal of screening is to detect disease at
More informationChristine Argento, MD Interventional Pulmonology Emory University
Christine Argento, MD Interventional Pulmonology Emory University Outline Lung Cancer Statistics Prior Studies for Lung Cancer Screening NLST Studies Following NLST Future Directions Lung Cancer American
More informationLung Cancer Risk Associated With New Solid Nodules in the National Lung Screening Trial
Cardiopulmonary Imaging Original Research Pinsky et al. Lung Cancer Risk Associated With New Nodules Cardiopulmonary Imaging Original Research Paul F. Pinsky 1 David S. Gierada 2 P. Hrudaya Nath 3 Reginald
More informationSocial and Behavioral Sciences for Tobacco Use
Social and Behavioral Sciences for Tobacco Use Bonnie L. Halpern-Felsher, Ph.D., FSAHM Professor Division of Adolescent Medicine Department of Pediatrics Tobacco Decision-Making Theoretical Framework Demographic
More informationLung Cancer Screening Computed Tomography Screening in Pa6ents at Risk for Lung Cancer
Lung Cancer Screening Computed Tomography Screening in Pa6ents at Risk for Lung Cancer Doug Arenberg, M.D. University of Michigan Disclosures Objec6ve Define patients who will benefit from screening for
More informationScreening for Lung Cancer - State of the Art
Screening for Lung Cancer - State of the Art Rohit Kumar, MD Assistant Professor of Medicine Fox Chase Cancer Center Temple University School of Medicine Philadelphia, PA Objectives Review current evidence
More informationSCBT-MR 2016 Lung Cancer Screening in Practice: State of the Art
SCBT-MR 2016 Lung Cancer Screening in Practice: State of the Art Reginald F. Munden MD, DMD, MBA I have no conflicts of interest to report National Lung Cancer Screening Trial 20% lung cancer mortality
More informationIntroduction and Background
CT Lung Cancer Screening and the Medical Physicist: Background, Findings and Participant Dosimetry Summary of the National Lung Screening Trial (NLST) Randell Kruger, PhD, DABR Medical Physics Section
More informationScreening for Lung Cancer. Michael S. Nolledo, MD Deborah Heart and Lung Center
Screening for Lung Cancer Michael S. Nolledo, MD Deborah Heart and Lung Center 1 1 Outline Ø Introduction Ø Lung Cancer Screening pre-2010 Ø Lung Cancer Screening today 2 2 Lung Cancer 2011 (Siegel et
More informationVeterans Health Administration Lung Cancer Screening Demonstration Project: Results & Lessons Learned
Veterans Health Administration Lung Cancer Screening Demonstration Project: Results & Lessons Learned Jane Kim, MD, MPH Acting Chief Consultant for Preventive Medicine National Center for Health Promotion
More informationOpen Access Review Article DOI: /cureus.589. Joshua Dajac 1, Jay Kamdar 1, Austin Moats 2, Brenda Nguyen 1
Open Access Review Article DOI: 10.7759/cureus.589 To Screen or not to Screen: Low Dose Computed Tomography in Comparison to Chest Radiography or Usual Care in Reducing Morbidity and Mortality from Lung
More informationLUNG CANCER SCREENING: ON WHOM DID YOU DO IT AND ON WHOM DO YOU RESPOND TO THE RESULTS?
LUNG CANCER SCREENING: ON WHOM DID YOU DO IT AND ON WHOM DO YOU RESPOND TO THE RESULTS? DAVID O. WILSON, MD, MHP DIRECTOR GEORGIA COOPER MEMORIAL LUNG CANCER RESEARCH REGISTRY UNIVERSITY OF PITTSBURGH
More informationProfessor John K Field PhD, FRCPath University of Liverpool Cancer Research Centre, UK.
Professor John K Field PhD, FRCPath University of Liverpool Cancer Research Centre, UK. J.K.Field@liv.ac.uk 1.8 million new cases in 2012 Bender Nature Outlook 2014 Probability of survival: ALL participants
More informationLung Cancer Screening In High Risk Populations:
Lung Cancer Screening In High Risk Populations: Michael Jaklitsch, M.D. Co-Chair of AATS Task Force on Lung Cancer Screening and Surveillance From the Brigham and Women s Hospital Harvard Medical School.
More informationScreening for Lung Cancer
Screening for Lung Cancer 15 ΜΑΡΤΙΟΥ 2014 Ioannis Gkiozos Pulmonologist Oncology Unit G P General & Chest Diseases Hospital Sotiria Despite advances in therapy, 5-year survival rates of Lung Cancer Remains
More informationLung Cancer Screening. Eric S. Papierniak, DO NF/SG VHA UF Health
Lung Cancer Screening Eric S. Papierniak, DO NF/SG VHA UF Health Overview Background Supporting evidence Guidelines Practical considerations Patient selection What to do with abnormal results Billing/coding
More informationNCCN Guidelines as a Model of Extended Criteria for Lung Cancer Screening
444 Original Research NCCN Guidelines as a Model of Extended Criteria for Lung Cancer Screening Brady J. McKee, MD; Shawn Regis, PhD; Andrea K. Borondy-Kitts, MS, MPH; Jeffrey A. Hashim, MD; Robert J.
More informationThe National Lung Screening Trial Research Team* A BS TR AC T
The new england journal of medicine established in 1812 august 4, 2011 vol. 365 no. 5 Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening The National Lung Screening Trial Research
More informationExample of lung screening
Justification of the use of CT for individual health assessment of asymptomatic people How to obtain evidence for IHA - Example of lung screening Mathias Prokop, MD PhD Professor of Radiology Radboud University
More informationLung Cancer Screening
Scan for mobile link. Lung Cancer Screening What is lung cancer screening? Screening examinations are tests performed to find disease before symptoms begin. The goal of screening is to detect disease at
More informationLung Cancer Screening Trials. Edward Harris Respiratory Research Fellow Sir Charles Gairdner Hospital
Lung Cancer Screening Trials Edward Harris Respiratory Research Fellow Sir Charles Gairdner Hospital Lung Cancer Screening in Australia Not Funded except as part of a clinical trial Rationale PLCO, ELCAP
More informationLung Cancer Screening: Radiologic and Clinical Implications. Katherine R. Birchard, M.D. University of North Carolina at Chapel Hill
Lung Cancer Screening: Radiologic and Clinical Implications Katherine R. Birchard, M.D. University of North Carolina at Chapel Hill Nothing to disclose Objectives In context of NLST: Review Imaging Techniques
More informationCT Low Dose Lung Cancer Screening. Part I. Journey to LDCT LCS Program
CT Low Dose Lung Cancer Screening Part I Journey to LDCT LCS Program Paul Johnson, M.S., DABHP, DABR Cleveland Clinic September 26, 2015 Lung Caner is No. 1 In Cancer Related Death In The United States
More informationNone
2014 None rosemary clooney Cancer is one of the most common diseases in the developed world: 1 in 4 deaths are due to cancer 1 in 17 deaths are due to lung cancer Lung cancer is the most common
More informationLung Cancer Screening: Who, What, Why? Myths Dispelled
Lung Cancer Screening: Who, What, Why? Myths Dispelled Presented By: MaryAnn Tateosian, RT (R), M, MM, CIIP MGH Lung Screening Program Manager December 11, 2018 1 Lung Screening Objectives History of Smoking
More informationGoals of Presentation
Goals of Presentation Review context of lung cancer screening why is it important? Review data from NLST supporting screening with lowdose CT (LDCT) scanning Discuss the pros and cons of LDCT screening
More informationScreening for Lung Cancer: Are We There Yet?
Screening for Lung Cancer: Are We There Yet? Kavita Garg, MD Professor of Radiology University of CO, Denver Mountain States Cancer Conference Nov 6 th 2010 The Epidemiology of Lung Cancer Tobacco is the
More informationAdverse Childhood Experiences (ACE) Results of Lake County Survey. Ferron & Associates for Children s Council of Lake County May 19, 2010
Adverse Childhood Experiences (ACE) Results of Lake County 2009-2010 Survey Ferron & Associates for Children s Council of Lake County May 19, 2010 Early Death Disease & Disability Health-Risk Behaviors
More informationLDCT Screening. Steven Kirtland, MD. Virginia Mason Medical Center February 27, 2015
LDCT Screening Steven Kirtland, MD Virginia Mason Medical Center February 27, 2015 2 Disclosures 4 5 Cancer Screening Mrs H 64yo 50 pk year smoker Lung Cancer Epidemiology Leading Cause of Cancer Death
More informationNC I CCC. A Comprehensive Cancer Center Designated by the National Cancer Institute
NC I CCC A Comprehensive Cancer Center Designated by the National Cancer Institute The Controversy About Lung Cancer Screening David S. Ettinger, M.D., FACP, FCCP Alex Grass Professor of Oncology The Sidney
More informationThe status of Lung Cancer Screening Guidelines. Peter B. Bach, MD, MAPP Memorial Sloan Kettering Cancer Center
The status of Lung Cancer Screening Guidelines Peter B. Bach, MD, MAPP Memorial Sloan Kettering Cancer Center bachp@mskcc.org @peterbachmd Homogeneity of guidelines But what about these? Outside the box
More informationSHARED DECISION MAKING IN MEDICARE COVERAGE
SHARED DECISION MAKING IN MEDICARE COVERAGE Kate Goodrich, MD MHS Director, Center for Clinical Standards and Quality CMS April 2, 2016 Disclaimer: Views and comments in this presentation are those of
More informationLearning Objectives. 1. Identify which patients meet criteria for annual lung cancer screening
Disclosure I, Taylor Rowlett, DO NOT have a financial interest /arrangement or affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in the context
More informationLung Cancer Screening: To Screen or Not to Screen?
Lung Cancer Screening: To Screen or Not to Screen? Lorriana Leard, MD Co-Director of UCSF Lung Cancer Screening Program Vice Chief of Clinical Activities UCSF Pulmonary, Critical Care, Allergy & Sleep
More informationUniversity of Connecticut. University of Connecticut Graduate School
University of Connecticut OpenCommons@UConn Master's Theses University of Connecticut Graduate School 5-7-2016 A Retrospective Study Assessing the Predictive Performance of a Lung Cancer Screening Risk
More informationLung cancer screening in Switzerland
SAMO Interdisciplinary Workshop on Chest Tumors 27 th and 28 th January 2017 Hotel Hermitage, Lucerne Lung cancer screening in Switzerland Walter Weder, MD, Professor of Surgery University Hospital Zurich,
More informationAmericans Current Views on Smoking 2013: An AARP Bulletin Survey
Americans Current Views on Smoking 2013: An AARP Bulletin Survey November 2013 Americans Current Views on Smoking 2013: An AARP Bulletin Survey Report Prepared by Al Hollenbeck, Ph.D. Copyright 2013 AARP
More informationHarnessing the Power of the DNP: Leading the Development and Implementation of an Evidence Based Clinical Program JOELLE FATHI, DNP, RN, ARNP, CTTS
Harnessing the Power of the DNP: Leading the Development and Implementation of an Evidence Based Clinical Program JOELLE FATHI, DNP, RN, ARNP, CTTS Objectives Identify innovative ways in which the DNP
More informationTobacco Use among VA Patients Receiving Lung Cancer Screening: Cessation at 1 year Post Screening
Tobacco Use among VA Patients Receiving Lung Cancer Screening: Cessation at 1 year Post Screening Zeliadt SB, Krebs P, Johnson H, Feemster LC, Klein D, Crothers K, Au D, Heffner J Presented by Paul Krebs,
More informationLUNG CANCER: LDCT DISCLOSURES NONE. Erika Swanson, MD Radiation Oncologist Ascension Columbia-St. Mary s February 1, /9/2018
LUNG CANCER: LDCT Erika Swanson, MD Radiation Oncologist Ascension Columbia-St. Mary s February 1, 2018 DISCLOSURES 2 NONE 1 OBJECTIVES 3 Rationale and evidence for LDCT for lung cancer screening Review
More informationEarly Detection of Lung Cancer. Amsterdam March 5 th 2010
Early Detection of Lung Cancer Amsterdam March 5 th 2010 Rob J van Klaveren, MD, PhD Dept. of Pulmonology Erasmus MC Rotterdam, the Netherlands Early Detection and Screening - Questions to be addressed
More informationElectronic Nicotine Delivery Systems: Patterns of Use and Disparities
Electronic Nicotine Delivery Systems: Patterns of Use and Disparities Daniel P. Giovenco, PhD, MPH Assistant Professor of Sociomedical Sciences Columbia University Mailman School of Public Health Outline
More informationSmoking Status and Body Mass Index in the United States:
Smoking Status and Body Mass Index in the United States: 1996-2000 Jun Yang, MD, PhD and Gary Giovino, PhD Roswell Park Cancer Institute Elm and Carlton Streets Buffalo, NY 14263, USA Society for Research
More informationMEDICAL POLICY SUBJECT: LOW-DOSE COMPUTED TOMOGRAPHY (LDCT) FOR LUNG CANCER SCREENING. POLICY NUMBER: CATEGORY: Technology Assessment
MEDICAL POLICY SUBJECT: LOW-DOSE COMPUTED CANCER SCREENING 05/18/05, 03/16/06, 12/21/06, 08/16/07, PAGE: 1 OF: 6 If a product excludes coverage for a service, it is not covered, and medical policy criteria
More informationRole of CT in Lung Cancer Screening: 2010 Stuart S. Sagel, M.D.
Role of CT in Lung Cancer Screening: 2010 Stuart S. Sagel, M.D. Lung Cancer 219,440 new cases/year in U.S. (2009) 169,390 deaths/year in U.S. mortality greater than from breast, colon, prostate CA combined
More informationObjectives. Why? Why? Background 11/5/ % incurable disease at presentation Locally advanced disease Metastasis. 14% 5 year survival
Objectives Appraise lung cancer screening trials results Review screening guidelines Lung Cancer Screening: Past, Present and Future Chi Wan Koo, MD Koo.chiwan@mayo.edu Discuss recommendations essential
More informationLung Cancer Screening: Current Status
Lung Cancer Screening: Current Status I have no financial relationships, arrangements or affiliations and this presentation will not include discussion of investigational or off-label use of a product
More informationScreening and Resistance to Cessation Efforts
Screening and Resistance to Cessation Efforts Elyse R. Park, Ph.D., MPH Associate Professor in Psychiatry, Massachusetts General Hospital/Harvard Medical School Funding Acknowledgements and Disclosures
More informationLung Cancer Screening. Ashish Maskey MD Interventional Pulmonology UK Health Care Dec 1 st 2017
Lung Cancer Screening Ashish Maskey MD Interventional Pulmonology UK Health Care Dec 1 st 2017 Nearly one in six American adults currently smoke cigarettes An estimated 40 million adults in the United
More informationClinical Trials. Susan G. Fisher, Ph.D. Dept. of Clinical Sciences
Clinical Trials Susan G. Fisher, Ph.D. Dept. of Clinical Sciences When to Do a RCT Exposure of interest is modifiable and individuals are willing to relinquish control Legitimate uncertainty exists about
More informationScreening for Lung Cancer: New Guidelines, Old Problems
Screening for Lung Cancer: New Guidelines, Old Problems Robert Schilz DO, PhD Associate Professor of Medicine Interim Chief of the Division of Pulmonary, Critical Care and Sleep Medicine University Hospitals
More informationGeneral principles of screening: A radiological perspective
General principles of screening: A radiological perspective Fergus Coakley MD, Professor and Chair, Diagnostic Radiology, Oregon Health and Science University General principles of screening: A radiological
More informationProjected Outcomes Using Different Nodule Sizes to Define a Positive CT Lung Cancer Screening Examination
DOI:10.1093/jnci/dju284 First published online October 20, 2014 The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
More informationCLINICAL GUIDELINES. Lung-Cancer Screening Program Guidelines Robert Y. Kanterman, M.D. and Thomas J. Gilbert, M.D., M.P.P.
CLINICAL GUIDELINES Lung-Cancer Screening Program Guidelines Robert Y. Kanterman, M.D. and Thomas J. Gilbert, M.D., M.P.P. 3/14/2015 Introduction: The purpose of a lung-cancer screening program is to detect
More informationCenter for Urban Initiatives and Research Wisconsin Public Health Survey December 2011 N=626. Frequency Tables (Weighted)
Center for Urban Initiatives and Research Wisconsin Public Health Survey December 2011 N=626 Tables (Weighted) Section 1: Opinions about chronic disease, health care funding, and chronic disease-related
More informationCancer Screenings and Early Diagnostics
Cancer Screenings and Early Diagnostics Ankur R. Parikh, D.O. Medical Director, Center for Advanced Individual Medicine Hematologist/Medical Oncologist Atlantic Regional Osteopathic Convention April 6
More informationRisk-Based Cancer Screening: Insights from the NLST
N L S T Risk-Based Cancer Screening: Insights from the NLST National Lung Screening Trial National Cancer Institute Christine D. Berg, MD Project Officer, NLST Former, Chief, Early Detection Research Group
More informationAmerican Cancer Society Lung Cancer Screening Guidelines
American Cancer Society Lung Cancer Screening Guidelines Richard Wender, MD 1 ; Elizabeth T. H. Fontham, MPH, DrPH 2 ; Ermilo Barrera, Jr, MD 3 ; Graham A. Colditz, MD, DrPH 4 ; Timothy R. Church, PhD
More informationIndeterminate Pulmonary Nodules in Patients with Colorectal Cancer
Indeterminate Pulmonary Nodules in Patients with Colorectal Cancer Jai Sule 1, Kah Wai Cheong 2, Stella Bee 2, Bettina Lieske 2,3 1 Dept of Cardiothoracic and Vascular Surgery, University Surgical Cluster,
More informationLung Cancer Screening: A review of the recommendations Friday, November 11th, 2016 from 11:45 to 12:15. Dr. Tunji Fatoye Dr.
Lung Cancer Screening: A review of the recommendations Friday, November 11th, 2016 from 11:45 to 12:15 Dr. Tunji Fatoye Dr. Alan Kaplan Conflict of Interest Disclosure: Speaker Name: Alan Kaplan FINANCIAL
More informationValidation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules
1 Stanford School of Medicine, Stanford, California, USA; 2 Duke University, Durham, North Carolina, USA; 3 Medical University of South Carolina, Charleston, South Carolina, USA; 4 VA Palo Alto Health
More informationSCBT-MR 2015 LungRADS : Basics
SCBT-MR 2015 LungRADS : Basics Reginald F. Munden MD, DMD, MBA I have no conflicts of interest to report National Lung Cancer Screening Trial 20% lung cancer mortality reduction 6.9% all cause mortality
More informationComparison of three mathematical prediction models in patients with a solitary pulmonary nodule
Original Article Comparison of three mathematical prediction models in patients with a solitary pulmonary nodule Xuan Zhang*, Hong-Hong Yan, Jun-Tao Lin, Ze-Hua Wu, Jia Liu, Xu-Wei Cao, Xue-Ning Yang From
More informationDisparity Data Fact Sheet General Information
Disparity Data Fact Sheet General Information Tobacco use is a well-recognized risk factor for many cancers, respiratory illnesses and cardiovascular diseases within Michigan. rates have continued to decline
More informationCT Lung Screening Implementation Challenges: State Based Initiatives
CT Lung Screening Implementation Challenges: State Based Initiatives Andrea McKee, MD Chair Radiation Oncology Lahey Hospital and Medical Center Co-Director Rescue Lung, Rescue Life Program Co-Chair Massachusetts
More informationChoosing Wisely. Objectives. Payal Sen PGY 1 Internal Medicine Residency Program University of New Mexico
Choosing Wisely Payal Sen PGY 1 Internal Medicine Residency Program University of New Mexico Financial Disclosure I have no relationships with any entity producing, marketing, reselling or distributing,
More informationLUNG CANCER SCREENING WHAT S THE IMPACT? Nitra Piyavisetpat, MD Department of Radiology Chulalongkorn University
LUNG CANCER SCREENING WHAT S THE IMPACT? Nitra Piyavisetpat, MD Department of Radiology Chulalongkorn University Objective LDCT lung cancer screening (LCS) Potential Benefits & Harms Recommendation of
More informationLung Cancer Screening
Lung Cancer Screening Preston Wright, DO University of Kansas School of Medicine- Wichita Family Medicine Residency at Via Christi Hospitals 1 Objectives Identify patients who need screened for lung cancer
More informationSubject: Low-Dose Helical (Spiral) Computed Tomography for Lung Cancer Screening Guidance Number: MCG-137 Revision Date(s): 5/13/2015
Subject: Low-Dose Helical (Spiral) Computed Tomography for Lung Cancer Screening Guidance Number: MCG-137 Revision Date(s): 5/13/2015 Original Effective Date: 6/26/2013 DESCRIPTION OF PROCEDURE/SERVICE/PHARMACEUTICAL
More informationSelected Controversies. Cancer Screening. Breast Cancer Screening. Selected Controversies. Page 1. Using Best Evidence to Guide Practice
Cancer Screening Using Best Evidence to Guide Practice Judith M.E. Walsh, MD, MH Division of General Internal Medicine Women s Health Center of Excellence University of California, San Francisco Selected
More informationMenthol Cigarettes, Smoking Cessation, Atherosclerosis and Pulmonary Function
Center for Regulatory Effectiveness (CRE) assessment of the following research report: Menthol Cigarettes, Smoking Cessation, Atherosclerosis and Pulmonary Function By: Mark J. Pletcher, MD, MPH; Benjamin
More informationCT Lung Screening Implementation Challenges: ALA/ATS Implementation Microsite
CT Lung Screening Implementation Challenges: ALA/ATS Implementation Microsite Andrea McKee, MD Chair Radiation Oncology Lahey Hospital and Medical Center November 2018 2016 data, 3 years after ACS recommendation
More information